Health13 hours ago
Akebia Therapeutics Abandons Vafseo Trial for Non-Dialysis Patients
Akebia Therapeutics has officially halted its plans to expand the indication for its drug Vafseo (vadadustat), aimed at treating anemia in patients with chronic kidney disease...